|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,278.00 INR | +0.13% |
|
-4.12% | +7.86% |
| 04:57am | Lupin Wins US FDA Nod for Abbreviated New Drug Application for Hyperkalemia Drug | MT |
| 08-10 | Lupin Gets FDA Approval for Hyperkalemia Drug | DJ |
| Market Cap | 1,040B 10.91B 9.44B 8.83B 8.07B 15.2B 15.44B 103B 40.61B 520B 40.95B 40.06B 1,733B | P/E 2027 * |
23.7x | P/E 2028 * | 22.3x |
|---|---|---|---|---|---|
| Enterprise Value | 996B 10.45B 9.05B 8.45B 7.73B 14.56B 14.79B 99.14B 38.9B 499B 39.23B 38.38B 1,660B | EV / Sales 2027 * |
3.29x | EV / Sales 2028 * | 3x |
| Free-Float |
52.97% | Yield 2027 * |
0.51% | Yield 2028 * | 0.56% |
Last Transcript: Lupin Limited
| 1 day | +0.13% | ||
| 1 week | -4.12% | ||
| Current month | -5.63% | ||
| 1 month | -8.74% | ||
| 3 months | -4.20% | ||
| 6 months | +3.34% | ||
| Current year | +7.86% |
| 1 week | 2,236 |  | 2,426.65 |
| 1 month | 2,236 | | 2,530 |
| Current year | 2,072.95 | | 2,530 |
| 1 year | 1,881.8 | | 2,530 |
| 3 years | 1,061.25 | | 2,530 |
| 5 years | 583.05 | | 2,530 |
| 10 years | 505 | | 2,530 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 01/09/2013 | |
| Director of Finance/CFO | 61 | 13/08/2007 | |
Amit Kumar Gupta
CMP | Compliance Officer | - | 01/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 52 | 08/10/2008 | |
| Director/Board Member | 58 | 01/01/1997 | |
| Chairman | 82 | 11/08/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.13% | -4.12% | +18.85% | +109.95% | 10.91B | |
| -0.85% | +9.73% | +92.73% | +131.74% | 1,098B | |
| -1.24% | +1.86% | +49.38% | +49.36% | 631B | |
| -0.11% | +1.79% | +24.93% | +63.07% | 438B | |
| -0.99% | +3.16% | +49.82% | +39.17% | 368B | |
| -0.69% | +1.00% | +31.06% | +38.62% | 298B | |
| -1.07% | +1.10% | +7.55% | +7.61% | 251B | |
| -0.84% | +6.20% | +45.29% | +57.78% | 226B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 209B | |
| +1.11% | -0.17% | +12.08% | +68.78% | 165B | |
| Average | -0.41% | +1,727.26% | +32.69% | +51.56% | 369.52B | |
| Weighted average by Cap. | -0.67% | +1,334.53% | +50.01% | +66.65% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 303B 3.18B 2.75B 2.57B 2.35B 4.43B 4.5B 30.18B 11.84B 152B 11.94B 11.68B 505B | 321B 3.36B 2.91B 2.72B 2.49B 4.69B 4.76B 31.92B 12.52B 160B 12.63B 12.35B 535B |
| Net income | 43.72B 458M 397M 371M 339M 639M 649M 4.35B 1.71B 21.87B 1.72B 1.68B 72.84B | 46.75B 490M 424M 397M 363M 683M 694M 4.65B 1.83B 23.39B 1.84B 1.8B 77.9B |
| Net Debt | -43.72B -458M -397M -371M -339M -639M -649M -4.35B -1.71B -21.87B -1.72B -1.68B -72.84B | -78.59B -824M -713M -667M -609M -1.15B -1.17B -7.82B -3.07B -39.32B -3.09B -3.03B -131B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | ₹2,278.00 | +0.13% | 158,968 |
| 10/08/26 | ₹2,275.00 | -3.60% | 196,912 |
| 07/08/26 | ₹2,360.00 | -1.32% | 58,561 |
| 06/08/26 | ₹2,391.50 | +0.23% | 18,638 |
| 05/08/26 | ₹2,386.00 | +0.42% | 38,844 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LUPIN Stock
Select your edition
All financial news and data tailored to specific country editions
